Best or Worst IdeaDay 3: Momentum Is Building
February 4, 2026 · Day 3 of 90
What Happened Today
Today VNDA showed its hand. Buyers are accumulating.
After dipping in pre-market, the stock ripped at the open — surging from $7.80 to $8.15 in minutes. It hit $8.22 by mid-morning before fading slightly into close at $8.05. Then after-hours popped it right back to $8.21.
This is classic pre-catalyst behavior. Investors are positioning ahead of two major events: earnings on February 11 and the FDA decision on February 21.
Today's Action
| Metric | Value |
|---|---|
| Pre-market | $7.80 (dipped early) |
| Open | $8.15 |
| 30 min | $8.22 |
| Close | $8.05 |
| After-hours | $8.21 |
| Day range | $7.80 – $8.22 (5.4%) |
Pattern Emerging: Dip → Rally → Fade → Pop
Three days in, a pattern is forming:
- Early dip (pre-market or at open)
- Rally through mid-morning
- Fade slightly into close
- Pop again in after-hours
This is accumulation. Buyers keep stepping in on weakness. That's bullish heading into catalysts.
The Thesis Is Upgrading
When we entered this trade, the thesis was simple: binary FDA catalyst on February 21.
Now we have two shots at momentum:
- February 11 — Q4 2025 Earnings: Nereus launch color, Bysanti commentary, revenue growth
- February 21 — Bysanti PDUFA: The main event, FDA approval/rejection
The earnings run-up is already happening. Buyers aren't waiting for February 21 — they're getting in now.
Current Position
| Ticker | Shares | Entry | Current | Value | P&L |
|---|---|---|---|---|---|
| VNDA | 129 | $7.82 | $8.05 | $1,038.45 | +$29.67 (+2.9%) |
The Three-Day Trend
| Day | Open | High | Close | Trend |
|---|---|---|---|---|
| Day 1 | $7.82 | $7.83 | $7.83 | Flat |
| Day 2 | $7.64 | $7.96 | $7.74 | Choppy |
| Day 3 | $8.15 | $8.22 | $8.05 | Breakout |
Higher highs. Higher lows. Uptrend confirmed.
Key Dates to Watch
| Date | Event | Days Away |
|---|---|---|
| Feb 10 | Day before earnings — reassess | 6 |
| Feb 11 | Q4 2025 Earnings | 7 |
| Feb 20 | Pre-PDUFA — options decision | 16 |
| Feb 21 | Bysanti FDA Decision | 17 |
Scoreboard
| Starting Capital | $1,000.00 |
|---|---|
| Current Value | $1,038.45 |
| Today's P&L | +$40.01 |
| Total Return | +3.8% |
| Day | 3 of 90 |
What's Next
We hold. Momentum is with us. The earnings run-up is real.
The sell limit at $10.50 remains active, but realistically we're watching for $8.50-$9.00 as the next decision point. If we get there before earnings, we'll consider trimming.
For now: let it ride.
87 days to go.
Disclaimer: This is a personal experiment for entertainment and educational purposes, not financial advice. Trading stocks and options involves significant risk — you can lose some or all of your money. I am not a licensed financial advisor. Do your own research before making any investment decisions. Past performance does not guarantee future results. If you sign up for Robinhood using my link, I may receive a referral bonus at no cost to you.